CLOROX CO /DE/ (CLX) Insider Transactions
Explore official ownership filings, with every record linked to its source.
CLX · CLOROX CO /DE/
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-09-23Filed 2026-09-25 | Peck Laurene EOfficer · VP - CAO & Corp ControllerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030. References: F1 | A Award / grantCommon Stock · Non-derivative | 2,192A | 83.94 | Direct | Form 4 ↗0001225208-26-007953 |
| 2026-09-23Filed 2026-09-25 | Marriner KirstenOfficer · EVP - Chief Admin OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030. References: F1 | A Award / grantCommon Stock · Non-derivative | 12,389A | 83.94 | Direct | Form 4 ↗0001225208-26-007952 |
| 2026-09-23Filed 2026-09-25 | Hyder Chris TOfficer · EVP-Chief Operating OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030. References: F1 | A Award / grantCommon Stock · Non-derivative | 13,342A | 83.94 | Direct | Form 4 ↗0001225208-26-007951 |
| 2026-09-23Filed 2026-09-25 | Bellet LucOfficer · EVP - Chief Financial OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030. References: F1 | A Award / grantCommon Stock · Non-derivative | 11,913A | 83.94 | Direct | Form 4 ↗0001225208-26-007950 |
| 2026-09-23Filed 2026-09-25 | Rendle Linda JDirector · Officer · Chief Executive OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030. References: F1 | A Award / grantCommon Stock · Non-derivative | 50,988A | 83.94 | Direct | Form 4 ↗0001225208-26-007949 |
| 2026-09-23Filed 2026-09-25 | Barton NinaOfficer · EVP-Chief Growth & Strategy OfFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030. References: F1 | A Award / grantCommon Stock · Non-derivative | 10,721A | 83.94 | Direct | Form 4 ↗0001225208-26-007948 |
| 2026-09-23Filed 2026-09-25 | Hilt Angela COfficer · EVP - Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2027, 2028, 2029, and 2030. References: F1 | A Award / grantCommon Stock · Non-derivative | 11,436A | 83.94 | Direct | Form 4 ↗0001225208-26-007947 |
| 2026-08-28Filed 2026-10-02 | WILLIAMS CHRISTOPHER JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F2, F3 | A Award / grantDeferred Stock Units · Derivative | 276.2573A | 0 | Direct | Form 4 ↗0001225208-26-008112 |
| 2026-08-28Filed 2026-10-02 | WEINER RUSSELL JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F2, F3 | A Award / grantDeferred Stock Units · Derivative | 226.7613A | 0 | Direct | Form 4 ↗0001225208-26-008111 |
| 2026-08-28Filed 2026-10-02 | Shattock Matthew JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F2, F3 | A Award / grantDeferred Stock Units · Derivative | 255.3782A | 0 | Direct | Form 4 ↗0001225208-26-008110 |
| 2026-08-28Filed 2026-10-02 | Plaines StephanieDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F2, F3 | A Award / grantDeferred Stock Units · Derivative | 98.9603A | 0 | Direct | Form 4 ↗0001225208-26-008109 |
| 2026-08-28Filed 2026-10-02 | Breber Pierre RDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Indirectly owned through family trust. F2 1-for-1 F3 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F4 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F5 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F2, F3, F4 | A Award / grantDeferred Stock Units · Derivative | 42.6144A | 0 | Direct | Form 4 ↗0001225208-26-008108 |
| 2026-07-22Filed 2026-07-24 | Barton NinaOfficer · EVP-Chief Growth & Strategy OfFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock. F2 Includes 229 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. References: F1, F2 | F WithholdingCommon Stock · Non-derivative | 1,681D | 95.69 | Direct | Form 4 ↗0001225208-26-006737 |
| 2026-07-15Filed 2026-07-17 | Hyder Chris TOfficer · EVP-Chief Operating OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock. F2 Includes 36 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan. References: F1, F2 | F WithholdingCommon Stock · Non-derivative | 277D | 94.75 | Direct | Form 4 ↗0001225208-26-006648 |
| 2026-06-30Filed 2026-07-02 | WILLIAMS CHRISTOPHER JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F4, F3 | A Award / grantDeferred Stock Units · Derivative | 288.1391A | 0 | Direct | Form 4 ↗0001225208-26-006380 |
| 2026-06-30Filed 2026-07-02 | WEINER RUSSELL JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F4, F3 | A Award / grantDeferred Stock Units · Derivative | 353.6253A | 0 | Direct | Form 4 ↗0001225208-26-006379 |
| 2026-06-30Filed 2026-07-02 | Shattock Matthew JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F4, F3 | A Award / grantDeferred Stock Units · Derivative | 550.0838A | 0 | Direct | Form 4 ↗0001225208-26-006378 |
| 2026-06-30Filed 2026-07-02 | Plaines StephanieDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F4, F3 | A Award / grantDeferred Stock Units · Derivative | 288.1391A | 0 | Direct | Form 4 ↗0001225208-26-006377 |
| 2026-06-30Filed 2026-07-02 | Breber Pierre RDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F4, F3 | A Award / grantDeferred Stock Units · Derivative | 353.6253A | 0 | Direct | Form 4 ↗0001225208-26-006376 |
| 2026-06-17Filed 2026-06-22 | Bellet LucOfficer · EVP - Chief Financial OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in full on the third anniversary of the grant date, June 17, 2029. References: F1 | A Award / grantCommon Stock · Non-derivative | 42,118A | 94.97 | Direct | Form 4 ↗0001225208-26-006140 |
| 2026-06-17Filed 2026-06-22 | Hilt Angela COfficer · EVP - Chief Legal OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in full on the third anniversary of the grant date, June 17, 2029. References: F1 | A Award / grantCommon Stock · Non-derivative | 26,324A | 94.97 | Direct | Form 4 ↗0001225208-26-006139 |
| 2026-06-17Filed 2026-06-22 | Marriner KirstenOfficer · EVP - Chief Admin OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in 3 equal installments - 1/3 on each of June 17, 2027, 2028 and 2029. References: F1 | A Award / grantCommon Stock · Non-derivative | 26,324A | 94.97 | Direct | Form 4 ↗0001225208-26-006138 |
| 2026-06-17Filed 2026-06-22 | Hyder Chris TOfficer · EVP-Chief Operating OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 The Restricted Stock Units will vest in full on the third anniversary of the grant date, June 17, 2029. References: F1 | A Award / grantCommon Stock · Non-derivative | 42,118A | 94.97 | Direct | Form 4 ↗0001225208-26-006137 |
| 2026-05-08Filed 2026-07-02 | WILLIAMS CHRISTOPHER JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F2, F3 | A Award / grantDeferred Stock Units · Derivative | 297.0104A | 0 | Direct | Form 4 ↗0001225208-26-006380 |
| 2026-05-08Filed 2026-07-02 | WEINER RUSSELL JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 1-for-1 F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan. F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director. F4 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees. References: F1, F2, F3 | A Award / grantDeferred Stock Units · Derivative | 242.2414A | 0 | Direct | Form 4 ↗0001225208-26-006379 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.